Literature DB >> 21587220

Too early to say, "no targeting of mitosis!".

Katsumi Kitagawa.   

Abstract

Mesh：

Substances：

Year:  2011        PMID： 21587220     DOI： 10.1038/nrclinonc.2010.228-c1

Source DB:  PubMed          Journal:  Nat Rev Clin Oncol        ISSN： 1759-4774            Impact factor:   66.675


× No keyword cloud information.
  10 in total

Review 1.  Mitosis is not a key target of microtubule agents in patient tumors.

Authors:  Edina Komlodi-Pasztor; Dan Sackett; Julia Wilkerson; Tito Fojo
Journal:  Nat Rev Clin Oncol       Date:  2011-02-01       Impact factor: 66.675

2.  p31comet Induces cellular senescence through p21 accumulation and Mad2 disruption.

Authors:  Miyong Yun; Young-Hoon Han; Sun Hee Yoon; Hee Young Kim; Bu-Yeo Kim; Yeun-Jin Ju; Chang-Mo Kang; Su Hwa Jang; Hee-Yong Chung; Su-Jae Lee; Myung-Haing Cho; Gyesoon Yoon; Gil Hong Park; Sang Hoon Kim; Kee-Ho Lee
Journal:  Mol Cancer Res       Date:  2009-03-10       Impact factor: 5.852

Review 3.  The kinetochore and the centromere: a working long distance relationship.

Authors:  Marcin R Przewloka; David M Glover
Journal:  Annu Rev Genet       Date:  2009       Impact factor: 16.830

4.  Relation between 9-aminocamptothecin systemic exposure and tumor response in human solid tumor xenografts.

Authors:  M N Kirstein; P J Houghton; P J Cheshire; L B Richmond; A K Smith; S K Hanna; C F Stewart
Journal:  Clin Cancer Res       Date:  2001-02       Impact factor: 12.531

5.  Relationships between tumor responsiveness, vincristine pharmacokinetics and arrest of mitosis in human tumor xenografts.

Authors:  J K Horton; P J Houghton; J A Houghton
Journal:  Biochem Pharmacol       Date:  1988-10-15       Impact factor: 5.858

6.  A requirement for breast-cancer-associated gene 1 (BRCA1) in the spindle checkpoint.

Authors:  Rui-Hong Wang; Hongtao Yu; Chu-Xia Deng
Journal:  Proc Natl Acad Sci U S A       Date:  2004-11-24       Impact factor: 11.205

7.  Comparison of cell proliferation kinetics in human and experimental tumors: response to irradiation.

Authors:  M Tubiana; E Malaise
Journal:  Cancer Treat Rep       Date:  1976-12

Review 8.  Integrating pharmacology and in vivo cancer models in preclinical and clinical drug development.

Authors:  J K Peterson; P J Houghton
Journal:  Eur J Cancer       Date:  2004-04       Impact factor: 9.162

9.  Cellular senescence induced by aberrant MAD2 levels impacts on paclitaxel responsiveness in vitro.

Authors:  M Prencipe; P Fitzpatrick; S Gorman; M Tosetto; M Mosetto; R Klinger; F Furlong; M Harrison; D O'Connor; I B Roninson; J O'Sullivan; A McCann
Journal:  Br J Cancer       Date:  2009-12-01       Impact factor: 7.640

10.  BUB1 mediation of caspase-independent mitotic death determines cell fate.

Authors:  Yohei Niikura; Amruta Dixit; Ray Scott; Guy Perkins; Katsumi Kitagawa
Journal:  J Cell Biol       Date:  2007-07-09       Impact factor: 10.539
  10 in total
  6 in total

1.  Identification of a mitotic death signature in cancer cell lines.

Authors:  Nandini Sakurikar; Joshua M Eichhorn; Sarah E Alford; Timothy C Chambers
Journal:  Cancer Lett       Date:  2013-10-04       Impact factor: 8.679

Review 2.  Microtubule destabilising agents: far more than just antimitotic anticancer drugs.

Authors:  Darcy Bates; Alan Eastman
Journal:  Br J Clin Pharmacol       Date:  2016-10-18       Impact factor: 4.335

3.  Cell Cycle-Dependent Mechanisms Underlie Vincristine-Induced Death of Primary Acute Lymphoblastic Leukemia Cells.

Authors:  Anisha Kothari; Walter N Hittelman; Timothy C Chambers
Journal:  Cancer Res       Date:  2016-05-06       Impact factor: 12.701

Review 4.  Why Great Mitotic Inhibitors Make Poor Cancer Drugs.

Authors:  Victoria C Yan; Hannah E Butterfield; Anton H Poral; Matthew J Yan; Kristine L Yang; Cong-Dat Pham; Florian L Muller
Journal:  Trends Cancer       Date:  2020-06-11

5.  The NOXA-MCL1-BIM axis defines lifespan on extended mitotic arrest.

Authors:  Manuel D Haschka; Claudia Soratroi; Susanne Kirschnek; Georg Häcker; Richard Hilbe; Stephan Geley; Andreas Villunger; Luca L Fava
Journal:  Nat Commun       Date:  2015-04-29       Impact factor: 14.919

6.  Primary acute lymphoblastic leukemia cells are susceptible to microtubule depolymerization in G1 and M phases through distinct cell death pathways.

Authors:  Magdalena Delgado; Randall R Rainwater; Billie Heflin; Alicja Urbaniak; Kaitlynn Butler; Mari Davidson; Reine M Protacio; Giulia Baldini; Andrea Edwards; Megan R Reed; Kevin D Raney; Timothy C Chambers
Journal:  J Biol Chem       Date:  2022-04-15       Impact factor: 5.486
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.